Scarica l'app Stockscreener
13.36
3.95%
-0.55
Dopo l'orario di chiusura:
13.36
Precedente Chiudi:
$13.91
Aprire:
$14.08
Volume 24 ore:
1.60M
Relative Volume:
1.23
Capitalizzazione di mercato:
$767.92M
Reddito:
$217.11M
Utile/perdita netta:
$-651.19M
Rapporto P/E:
-1.0285
EPS:
-12.99
Flusso di cassa netto:
$-387.26M
1 W Prestazione:
+4.21%
1M Prestazione:
+36.05%
6M Prestazione:
-12.11%
1 anno Prestazione:
-72.40%
Intervallo 1D:
$12.93
$14.61
Intervallo di 1 settimana:
$11.35
$14.61
Portata 52W:
$5.26
$64.40
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Nome
Ginkgo Bioworks Holdings Inc
Settore
Industria
Telefono
(877) 442-5362
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Confronta DNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
13.36 | 767.92M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-15 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-05-10 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-02 | Downgrade | Goldman | Neutral → Sell |
| 2023-05-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-10-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-02-23 | Iniziato | Goldman | Neutral |
| 2022-02-01 | Iniziato | BofA Securities | Neutral |
| 2022-01-28 | Iniziato | BofA Securities | Buy |
| 2022-01-07 | Iniziato | BTIG Research | Buy |
| 2021-11-29 | Iniziato | Jefferies | Buy |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-10-12 | Iniziato | William Blair | Outperform |
| 2021-09-20 | Iniziato | HSBC Securities | Buy |
Mostra tutto
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Ginkgo Bioworks (NYSE:DNA) Trading Down 6.3%Time to Sell? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading 9.7% HigherWhat's Next? - MarketBeat
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Vanguard Group Inc Reduces Stake in Ginkgo Bioworks Holdings Inc - GuruFocus.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -0.24%: What You Should Know - MSN
Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' Path (NYSE:DNA) - Seeking Alpha
Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States - Marketscreener.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Stock Position Reduced by Exchange Traded Concepts LLC - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap DownWhat's Next? - MarketBeat
Ginkgo (DNA) to Report Q2 Earnings: What's in the Cards? - MSN
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Barclays PLC - MarketBeat
Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC) - Marketscreener.com
Ginkgo Bioworks Secures Major Lab Automation Contract with DOE Research Center at UW-Madison - StockTitan
Ginkgo Bioworks (NYSE:DNA) Trading Up 6.4%What's Next? - MarketBeat
SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development - Marketscreener.com
Ginkgo Bioworks (NYSE:DNA) Trading 9.1% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpStill a Buy? - MarketBeat
DNAGinkgo Bioworks Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors - PR Newswire
Ginkgo Bioworks Partners with Astellas' Universal Cells to Advance Cancer Cell Therapy Innovation - StockTitan
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 9.1%What's Next? - MarketBeat
(DNA) On The My Stocks Page - Stock Traders Daily
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
Barclays PLC Trims Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks officer sells stock for $3,796 By Investing.com - Investing.com Canada
Ginkgo Bioworks officer sells stock for $3,796 - Investing.com India
Ginkgo Bioworks (NYSE:DNA) Trading 6.5% HigherHere's Why - MarketBeat
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Geode Capital Management LLC Trims Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by State Street Corp - MarketBeat
(DNA) Trading Advice - Stock Traders Daily
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 7.9%Here's Why - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 6.6%Here's What Happened - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 1,865,335 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 4.1%What's Next? - MarketBeat
Teachers Retirement System of The State of Kentucky Cuts Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to Buy - MSN
Ginkgo Bioworks joins project on cell-based disease treatment By Investing.com - Investing.com South Africa
Ginkgo Bioworks joins project on cell-based disease treatment - Investing.com
Ginkgo Bioworks Lands $9.4M Contract for Groundbreaking Bioelectronic Treatment Technology - StockTitan
Charles Schwab Investment Management Inc. Decreases Stock Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement - Law360
Janus Henderson Group PLC Has $118,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo to Pay $17.8 Million in Class Deal Over SPAC Merger, IPO - Bloomberg Law
Ginkgo Bioworks (NYSE:DNA) Trading Down 5.5%What's Next? - MarketBeat
Verition Fund Management LLC Takes Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Lowers Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):